Frazier Life Sciences Management, L.P. Verona Pharma PLC Transaction History
Frazier Life Sciences Management, L.P.
- $1.86 Billion
- Q3 2024
A detailed history of Frazier Life Sciences Management, L.P. transactions in Verona Pharma PLC stock. As of the latest transaction made, Frazier Life Sciences Management, L.P. holds 3,383,950 shares of VRNA stock, worth $144 Million. This represents 5.24% of its overall portfolio holdings.
Number of Shares
3,383,950
Previous 3,314,349
2.1%
Holding current value
$144 Million
Previous $47.9 Million
103.14%
% of portfolio
5.24%
Previous 2.82%
Shares
6 transactions
Others Institutions Holding VRNA
# of Institutions
167Shares Held
68.7MCall Options Held
704KPut Options Held
685K-
Perceptive Advisors LLC New York, NY6.32MShares$270 Million4.75% of portfolio
-
Nea Management Company, LLC Timonium, MD5.58MShares$238 Million12.27% of portfolio
-
Ra Capital Management, L.P. Boston, MA5.01MShares$214 Million2.01% of portfolio
-
Lee Ainslie Maverick Capital LTD | Dallas, Tx4.22MShares$180 Million2.52% of portfolio
-
Vivo Capital, LLC Palo Alto, CA3.55MShares$152 Million14.95% of portfolio
About Verona Pharma plc
- Ticker VRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 60,954,200
- Market Cap $2.6B
- Description
- Verona Pharma plc, a clinical stage biopharmaceutical company, focuses on development and commercialization of therapies for the treatment of respiratory diseases with unmet medical needs. The company's product candidate is ensifentrine, an inhaled and dual inhibitor of the phosphodiesterase (PDE) 3 and PDE4 enzymes that acts as both a bronchodi...